To screen or not is not the question--it is when and how to screen

Editorial

A J Marian et al. Circulation. 2003.

. 2003 May 6;107(17):2171-4.

doi: 10.1161/01.CIR.0000068686.12195.C2.

No abstract available

Comment on

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.
Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M; EUROGENE Heart Failure Project. Richard P, et al. Circulation. 2003 May 6;107(17):2227-32. doi: 10.1161/01.CIR.0000066323.15244.54. Epub 2003 Apr 21. Circulation. 2003. PMID: 12707239

1. Watson JD, Crick FH. Molecular structure of nucleic acids: a structure for deoxyribose nucleic acid. Nature. 1953;171:737–738. - PubMed
1. National Center for Biotechnology Information. GenBank. Completed and Ongoing Projects. [Accessed April 4, 2003]. Available at: http://www.ncbi.nlm.nih.gov/PMGifs/Genomes/bact.html.
1. Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. [Accessed April 4, 2003]. Available at: http://archive.uwcm.ac.uk/uwcm/mg/hgmd0.html.
1. Geisterfer-Lowrance AA, Kass S, Tanigawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999–1006. - PubMed
1. Marian AJ, Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol. 2001;33:655–670. - PMC - PubMed